FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
CorMedix reports $127 million Q4 revenue, provides 2026 outlook
Post Content
Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia
Post Content
CorMedix announces leadership changes with CEO taking chairman role
Post Content
Walmart appoints Superhuman CEO Shishir Mehrotra to board of directors
Post Content
Beyond Oil appoints telecom exec Dganit Kramer to advisory board
Post Content
Oil’s ‘Maduro trade’ faded fast — and won’t come back until Venezuela stabilizes
Economic rebuilding depends on the U.S. lifting sanctions. The wait for Venezuela — and U.S. companies — could be long.
Global defense stocks advance after Trump calls for higher US military budget
Post Content
JPMorgan cuts ties with proxy advisers, to replace with in-house AI, WSJ reports
Post Content
Media startup Semafor raises $30M in new financing, WSJ reports
Post Content